Kottil Rammohan
Payments from drug & device makers
$4,963,250in general payments, 2019–2025
Across 732 payments — averaging $6780.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$1.6M
- AstraZeneca$770K
- Genentech, Inc.$665K
- Sanofi$461K
- Novartis$459K
- Biogen$309K
- plus $687K from 18 others
$21,988in research payments, 2019–2025
Across 6 payments — averaging $3664.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$20K
- F. Hoffmann-la Roche AG$2K
- Sanofi$100
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 281 | $1,611,934 |
| AstraZeneca | 45 | $770,259 |
| Genentech, Inc. | 41 | $664,520 |
| Sanofi | 43 | $460,666 |
| Novartis | 47 | $459,037 |
| Biogen | 27 | $309,420 |
| Roche Products Limited | 41 | $244,279 |
| TG Therapeutics, Inc. | 30 | $230,333 |
| Hoffmann-la Roche Limited | 13 | $76,681 |
| EMD Serono, Inc. | 89 | $63,987 |
| Genentech USA, Inc. | 21 | $23,079 |
| Mallinckrodt Hospital Products Inc. | 2 | $15,900 |
| Chugai Pharmaceutical Co., Ltd. | 3 | $13,739 |
| Amgen(2 entities) | 17 | $7,765 |
| Merck Kgaa | 3 | $6,880 |
| Novartis Pharma AG | 1 | $1,410 |
| Bristol Myers Squibb | 14 | $1,097 |
| Hexal AG | 1 | $940 |
| Mallinckrodt Enterprises LLC | 3 | $723 |
| Saol Therapeutics Inc. | 2 | $180 |
| Sandoz | 4 | $162 |
| Axonics, Inc. | 1 | $146 |
| Johnson & Johnson | 2 | $100 |
| Banner Life Sciences, LLC | 1 | $15 |
How this compares
$4,963,250 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Miami
- Michael PfefferMiami$24.5M
- Silvia DelgadoMiami$11M
- Angel CarrascoMiami$10.3M
- Michael BenatarMiami$5.4M
- Macarena de la FuenteMiami$4.9M
- Victor FaradjiMiami$4M
- Brad HerskowitzMiami$3.1M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.